Lief Therapeutics
Only clinically oriented HRV biofeedback wearable with integrated licensed-therapist coaching and insurance-reimbursable pathways
REGISTERED
Registered with the FDA but NOT cleared or approved. Administrative listing only — no safety evaluation.
Key facts at a glance.
- Founded
- 2016
- Headquarters
- San Francisco, CA, USA
- Price range
- $299–$299
- App ratings
- iOS 3.8 · Android 3.5
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $299 |
| Subscription$99/mo × 36mo | $3,564 |
| 3-year total | $3,863 |
What the device does.
- + Adhesive chest patch with continuous medical-grade ECG
- + Real-time HRV biofeedback with guided paced-breathing vibrations
- + Clinician dashboard for remote patient monitoring
- + Lief Coaching with licensed therapists
- + CPT reimbursement pathway for HRV biofeedback
- + Daily HRV, stress, and resilience scores
- + Discreet under-clothing form factor
The trade-offs.
- + **Only HRV biofeedback wearable with integrated licensed-therapist coaching**
- + Insurance-reimbursable pathways through clinical positioning
- + FDA-registered (more regulated positioning than general-wellness alternatives)
- + 2016-founded with established clinical-channel adoption
- − **$99/mo subscription** — meaningfully expensive vs alternatives
- − $299 hardware + $99/mo subscription = $3,863 / 3 yr (vs Whoop $1,080)
- − 3.8 iOS / 3.5 Android app ratings — mid-tier consumer signal
- − Clinical-channel positioning less DTC-friendly than mainstream wearables
- − Smaller brand awareness outside therapy / mental-health-treatment context
People with anxiety, stress, PTSD, or depression; telehealth patients seeking HRV biofeedback therapy
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Lief Therapeutics is the clinically oriented HRV biofeedback wearable specialist with licensed-therapist coaching — founded 2016 in San Francisco, with structural value claim built on only consumer wearable integrating HRV biofeedback with licensed-therapist coaching + insurance-reimbursable clinical pathways + FDA-registered positioning. The clinical-channel positioning is structurally distinct from consumer-DTC HRV alternatives.
The structural editorial caveats: $99/mo subscription is expensive (~$3,863 / 3 yr including hardware vs Whoop’s $1,080), 3.8/3.5 app ratings mid-tier, clinical-channel positioning less DTC-friendly, and smaller brand awareness outside therapy context.
When Lief Makes Sense
Strong fit: Therapy / mental-health treatment integration; insurance-reimbursable clinical pathway; licensed-therapist coaching priority; FDA-registered positioning preference.
Weaker fit: Subscription-cost-priority (Polar / COROS / HeartMath are no-subscription); largest review base / consumer signal; DTC consumer-direct positioning; cost-priority HRV measurement.
3-Year Cost of Ownership
| Use case | Cost |
|---|---|
| Lief hardware | ~$299 |
| $99/mo subscription | ~$3,564 / 3 yr |
| 3-year total | ~$3,863 |
Compare: Whoop ($1,080 / 3 yr), HeartMath Inner Balance ($49-495 lifetime sub), Polar H10 + Vantage V3 ($650-700 no subscription), Apollo Neuro ($349), Oura Ring 4 ($565 / 3 yr).
Verdict: Conditional
Lief Therapeutics earns a conditional verdict on its only-clinically-oriented HRV biofeedback wearable with licensed-therapist coaching, insurance-reimbursable pathways, FDA-registered positioning, and 2016-founded clinical-channel adoption — balanced against $99/mo subscription making 3-year cost ~$3,863 (3.6× Whoop), mid-tier app ratings, clinical-channel positioning less DTC-friendly, and smaller brand awareness outside therapy context.
For therapy / mental-health users wanting licensed-therapist coaching with insurance-reimbursable HRV biofeedback, structurally appropriate. For cost-priority, consumer-direct DTC, or subscription-averse positioning, alternatives are better matched.
Changelog
- 2026-05-07: Initial review published based on published specifications and consumer signal documentation.
What we'll measure on the bench.
- Protocol
- Polar H10 (paired strap)
- Primary metric
- HRV (RMSSD) Bland–Altman bias
- Pass threshold
- ±5 ms bias · ±15 ms 95% LoA
- Session shape
- 7 morning resting + 3 active sessions
§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.